Countries around the Persian Gulf are falling behind with regard to renewables, both for technical and for political reasons. And they need to diversify — just like the rest of us — if they are going to keep local consumption from using up too much of the oil they would rather sell.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.

Altering the Medicare policy on injectable drugs is one way to reduce Medicare expenditures. Allowing self-administration will also free up hospital and clinic capacity for other patients.

This article focuses on three early cases of the Arab Spring — Tunisia, Egypt and Morocco — to discuss causes and likely outcomes, gender dynamics, prospects for genuine democratization, and the connection between feminist movements and democratization. A comparative and international perspective highlights similarities and differences across the Arab cases and between the Arab Spring and other "democracy waves."

To access the full article, download the PDF on the left-hand sidebar.

By Karen E. Hoffman, Jiangong Niu, Sharon H…

By Bruce Y. Lee, Kristina M. Bacon, Maria Elena Bottazzi and Peter J. Hotez

Abstract

Background: As Chagas disease…

The evolution of revenue efficiency of national oil companies (NOCs) is examined using data on 61 oil companies from 2001-09. Published by The Energy Journal.

Abstract

Kingpin strategies— the targeting of the top-levels of terrorist or drug trafficking organization hierarchies—…

Introduction

With a new year and a new administration in Mexico we can expect continuity in substantive policy and…

Despite the political nature of stem cell research, this area of science continues to flourish in the United States. In 2011, the NIH funded approximately US$1.2 billion in stem cell research — a steady increase from past years — with US$123 million devoted to human embryonic stem cells. According to the ISI Web of Science, more than 4,000 U.S.-authored stem cell publications were produced in 2011, accounting for approximately 38 percent of the world total. Approximately one-quarter of these publications were collaborations with authors from other countries.